Skip Ribbon Commands
Skip to main content
Sign In

26824 Insulin Autoantibodies (IAA) (FINAB)

Insulin Autoantibodies (IAA) (FINAB)
Test Code: FINABSO
Synonyms/Keywords

​​IAA, Insulin Antibodies​​

Specimen Requirements
Specimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​Serum
​Serum Separator Tube (SST)
​Red Top Tube (RTT)
​0.5 mL
​0.5 mL
​​0.2 mL
Collection Processing Instructions

​​1. Within 1 hour of collection, centrifuge and aliquot 0.5 mL of serum into plastic vial.

2. Freeze immediately after separation and send frozen.

**Note: No radioactive isotopes should be administered 24 hours prior to venipuncture.

Specimen Stability Information
Specimen Type
TemperatureTime
​Serum​

​Frozen (preferred)
​Unspecified
​Refrigerated
​72 hours
Rejection Criteria

​Thawing (if remains cold = ok; if warm = reject); Radioactive isotopes administerd 24 hours prior to veinipuncture.

Performing Laboratory Information
Performing Location
Day(s) Test PerformedAnalytical TimeMethodology/Instrumentation
Mayo Clinic Laboratories​​
​Monday - Sunday
10-17 days

Insulin-I125 binding capacity

​Mayo sends specimens to Esoterix Endocrinology for testing.​ ​ ​
Reference Lab
Test Information

​​This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Type 1 diabetes, commonly referred to as insulin-dependent diabetes mellitus (IDDM), is caused by pancreatic beta-cell destruction that leads to an absolute insulin deficiency.(1) The clinical onset of diabetes does not occur until 80% to 90% of these cells have been destroyed. Prior to clinical onset, type 1 diabetes is often characterized by circulating autoantibodies against a variety of islet cell antigens, including glutamic acid decarboxylase (GAD), tyrosine phosphatase (IA2), and insulin.(2-5) The autoimmune destruction of the insulin-producing pancreatic beta cells is thought to be the primary cause of type 1 diabetes. The presence of these autoantibodies provides early evidence of autoimmune disease activity, and their measurement can be useful in assisting the physician with the prediction, diagnosis, and management of patients with diabetes. Insulin is the only beta-cell specific autoantigen thus far identified.(4-6) Antibodies to insulin are found predominantly, though not exclusively, in young children developing type 1 diabetes. In insulin-naive (untreated) patients, the prevalence of antibodies to insulin is almost 100% in very young individuals and almost absent in adult onset of type 1 diabetes. Because the risk of diabetes is increased with the presence of each additional autoantibody marker, the positive predictive value of insulin antibody measurement is increased when measured in conjunction with antibodies to GAD and IA2.(2-4)​

Reference Range Information

Negative: <5.0 uU/mL

Positive: > or = 5.0 uU/mL​

Outreach CPTs
CPT

Modifier
(if needed)
QuantityDescriptionComments
86337​
​1
Synonyms/Keywords

​​IAA, Insulin Antibodies​​

Ordering Applications
Ordering Application
Description
​Cerner
​​Insulin Autoantibodies (IAA)

If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​Serum
​Serum Separator Tube (SST)
​Red Top Tube (RTT)
​0.5 mL
​0.5 mL
​​0.2 mL
Collection Processing

​​1. Within 1 hour of collection, centrifuge and aliquot 0.5 mL of serum into plastic vial.

2. Freeze immediately after separation and send frozen.

**Note: No radioactive isotopes should be administered 24 hours prior to venipuncture.

Specimen Stability Information
Specimen Type
TemperatureTime
​Serum​

​Frozen (preferred)
​Unspecified
​Refrigerated
​72 hours
Rejection Criteria

​Thawing (if remains cold = ok; if warm = reject); Radioactive isotopes administerd 24 hours prior to veinipuncture.

Reference Range Information

Negative: <5.0 uU/mL

Positive: > or = 5.0 uU/mL​

For more information visit:
Performing Laboratory Information
Performing Location
Day(s) Test PerformedAnalytical TimeMethodology/Instrumentation
Mayo Clinic Laboratories​​
​Monday - Sunday
10-17 days

Insulin-I125 binding capacity

​Mayo sends specimens to Esoterix Endocrinology for testing.​ ​ ​
Reference Lab
For billing questions, see Contacts
Outreach CPTs
CPT

Modifier
(if needed)
QuantityDescriptionComments
86337​
​1
For most current information refer to the Marshfield Laboratory online reference manual.